The design of effective in vivo antagonists of rat uterus and milk ejection responses to oxytocin. 1980

W H Sawyer, and J Haldar, and D Gazis, and J Seto, and K Bankowski, and J Lowbridge, and A Turan, and M Manning

Several new synthetic analogs of the oxytocin antagonist [1-deaminopenicillamine]oxytocin have been prepared and tested for their abilities to inhibit responses to oxytocin by the isolated rat uterus in the absence and presence of Mg++, by the rat uterus in situ, and by the rat mammary gland in situ. Substituting 2-O-methyltyrosine in [1-deaminopenicillamine]oxytocin strikingly enhances antagonism of all uterin responses, and [1-deaminopenicillamine, 2-O-methyltyrosine]oxytocin and its 4-threonine analog are also potent inhibitors of the milk ejection response. Substituting 2-phenylalanine in [1-deaminopenicillamine]oxytocin also enhances antagonistic activities in all uterine assays, but [1-deaminopenicillamine, 2-phenylalanine]oxytocin retains agonistic activity on milk ejection assays. From these studies we can conclude that changes in the 1-position (1-deaminopenicillamine substitution) and the 2-position (2-O-methyltyrosine or 2-phenylalanine substitution) can have additive effects on antagonistic activities. Substitution of an 8-ornithine also enhances inhibitory potency in vivo, and this effect may also be additive to those of the substitutions in 1- and 2-positions. These findings provide many clues that may lead to the design of even more effective antagonists; several of the analogs reported here appear to the most effective antagonists of oxytocin in vivo yet reported and may be useful agents in further studies on the physiological functions of endogenous oxytocin.

UI MeSH Term Description Entries
D007774 Lactation The processes of milk secretion by the maternal MAMMARY GLANDS after PARTURITION. The proliferation of the mammary glandular tissue, milk synthesis, and milk expulsion or let down are regulated by the interactions of several hormones including ESTRADIOL; PROGESTERONE; PROLACTIN; and OXYTOCIN. Lactation, Prolonged,Milk Secretion,Lactations, Prolonged,Milk Secretions,Prolonged Lactation,Prolonged Lactations
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D008781 Methyltyrosines A group of compounds that are methyl derivatives of the amino acid TYROSINE.
D008893 Milk Ejection Expulsion of milk from the mammary alveolar lumen, which is surrounded by a layer of milk-secreting EPITHELIAL CELLS and a network of myoepithelial cells. Contraction of the myoepithelial cells is regulated by neuroendocrine signals. Milk Let-down,Ejection, Milk,Milk Let down
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

W H Sawyer, and J Haldar, and D Gazis, and J Seto, and K Bankowski, and J Lowbridge, and A Turan, and M Manning
May 1954, American journal of obstetrics and gynecology,
W H Sawyer, and J Haldar, and D Gazis, and J Seto, and K Bankowski, and J Lowbridge, and A Turan, and M Manning
January 1986, Physiology & behavior,
W H Sawyer, and J Haldar, and D Gazis, and J Seto, and K Bankowski, and J Lowbridge, and A Turan, and M Manning
March 1980, Endocrinology,
W H Sawyer, and J Haldar, and D Gazis, and J Seto, and K Bankowski, and J Lowbridge, and A Turan, and M Manning
January 1971, Acta endocrinologica. Supplementum,
W H Sawyer, and J Haldar, and D Gazis, and J Seto, and K Bankowski, and J Lowbridge, and A Turan, and M Manning
January 1971, Acta endocrinologica. Supplementum,
W H Sawyer, and J Haldar, and D Gazis, and J Seto, and K Bankowski, and J Lowbridge, and A Turan, and M Manning
July 1966, Chemical & pharmaceutical bulletin,
W H Sawyer, and J Haldar, and D Gazis, and J Seto, and K Bankowski, and J Lowbridge, and A Turan, and M Manning
April 1990, Endocrinology,
W H Sawyer, and J Haldar, and D Gazis, and J Seto, and K Bankowski, and J Lowbridge, and A Turan, and M Manning
June 1973, The Journal of endocrinology,
W H Sawyer, and J Haldar, and D Gazis, and J Seto, and K Bankowski, and J Lowbridge, and A Turan, and M Manning
September 1970, Journal of dairy science,
W H Sawyer, and J Haldar, and D Gazis, and J Seto, and K Bankowski, and J Lowbridge, and A Turan, and M Manning
May 2004, Journal of dairy science,
Copied contents to your clipboard!